Tocilizumab and the risk of respiratory adverse events in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomised controlled trials

Clinical and experimental rheumatology

Volumn 37, Issue 2, 2019, Pages 318-323

  Geng, Zhe ^a   Yu, Yikai ^a   Hu, Shaoxian ^a   Dong, Lingli ^a   Ye, Cong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY; TOCILIZUMAB;

ADULT; CHEMICALLY INDUCED; HUMAN; META ANALYSIS; RESPIRATORY TRACT DISEASE; RHEUMATOID ARTHRITIS;

ADALIMUMAB; ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; RESPIRATORY TRACT DISEASES;

EID: 85063646271     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)